CHI3L1 and in situ carcinoma: Elevated levels of CHI3L1 in the CSF have been reported in MS patients compared to healthy controls, and increased CHI3L1 expression has been associated with the transition from clinically isolated syndrome (CIS) to definite MS [9,16,17,18,19,20,21].